Medtronic (MDT) Tops Q2 EPS by 2c; Guides FY23 EPS Below the Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St futures gain on tech rebound, Middle East peace hopes
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil falls as traders digest escalation in US-Iran strikes
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
- UBS sees generational semiconductor boom, highlights stock winners
Medtronic reports second quarter fiscal 2023 financial results
November 22, 2022 6:45 AM ESTEarnings delivered despite slower market procedure volume and supply recovery; Growth driven by TAVR, Pacing, U.S. Core Spine, and International Diabetes
DUBLIN, Nov. 22, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2023, which ended October 28, 2022.
Key Highlights
Revenue of $7.6 billion decreased 3% as reported and increased 2% organicGAAP diluted EPS of $0.32 decreased 67%; non-GAAP diluted EPS of $1.30 decreased 2%Company updates guidance; expects... More